![Avinash Rao Ullur, MD DNB FASN AHSCP-CHS on Twitter: "1/12 ❓What treatment option comes to your mind when you think of a patient with CKD who: - needs rapid iron repletion - Avinash Rao Ullur, MD DNB FASN AHSCP-CHS on Twitter: "1/12 ❓What treatment option comes to your mind when you think of a patient with CKD who: - needs rapid iron repletion -](https://pbs.twimg.com/media/ExQoTu-XAAAEUwy.png)
Avinash Rao Ullur, MD DNB FASN AHSCP-CHS on Twitter: "1/12 ❓What treatment option comes to your mind when you think of a patient with CKD who: - needs rapid iron repletion -
![Abstract 13788: Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure | Circulation Abstract 13788: Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure | Circulation](https://www.ahajournals.org/cms/asset/a1bcbf67-389d-44bf-be00-a9312b639ae9/g13788.jpg)
Abstract 13788: Intravenous Iron Replacement Therapy With Ferric Carboxymaltose is Safe and Effective in Pediatric Patients With Heart Failure | Circulation
![Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide - Journal of Oncology Navigation & Survivorship Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide - Journal of Oncology Navigation & Survivorship](https://www.jons-online.com/images/JONS/issues/2022/September/roadmap-qr.png)
Navigating Iron Deficiency Anemia: My IV Iron Treatment Guide - Journal of Oncology Navigation & Survivorship
![Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial - The Lancet Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial - The Lancet](https://www.thelancet.com/cms/asset/4b0be126-d77f-42f1-a9c2-5fa0b3518849/gr1.jpg)
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial - The Lancet
![Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials | SpringerLink Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00392-021-01837-8/MediaObjects/392_2021_1837_Figa_HTML.png)
Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials | SpringerLink
![Presurgical IV iron does not PREVENTT post-surgical mortality in anaemic patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy Presurgical IV iron does not PREVENTT post-surgical mortality in anaemic patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy](https://pubmiddleware.mims.com/resource/image/C940A95A-25FF-408F-B7B5-AC64012C5A1D/OriginalThumbnail/THUMBNAIL_shutterstock_1598252035.jpg)